BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1684 related articles for article (PubMed ID: 17943779)

  • 1. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Bahadue FL; Soll R
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
    Lemyre B; Davis PG; De Paoli AG; Kirpalani H
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003212. PubMed ID: 28146296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
    Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
    Subramaniam P; Ho JJ; Davis PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal high flow therapy for primary respiratory support in preterm infants.
    Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
    Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Walker E; Osborn DA
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive high-frequency ventilation in newborn infants with respiratory distress.
    Abdel-Latif ME; Tan O; Fiander M; Osborn DA
    Cochrane Database Syst Rev; 2024 May; 5(5):CD012712. PubMed ID: 38695628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
    Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
    Lemyre B; Davis PG; De Paoli AG; Kirpalani H
    Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants.
    Subramaniam P; Ho JJ; Davis PG
    Cochrane Database Syst Rev; 2016 Jun; (6):CD001243. PubMed ID: 27315509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.